Combination comprising 5-[4-]2-(N-methyl-N-(2-pyridyl) amino)ethoxy] benzyl]thiazolidine-2,4-dione and metformin

PK139901AUndetermined Publication Date: 2009-01-03S MITHKLINE BEECHAM PLC
0 Cites 0 Cited by

Patent Information

Application Number
PK199800631
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-01-03
Patent Text Reader

Abstract

A combination comprising from 2 to 8 mg of 5-[4-]2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione (compound (I) in a pharmaceutically acceptable form and upto 3000 mg of metformin in a pharmaceutically acceptable form, and a pharmaceutical composition comprising the same, for use in the treatment of diabetes mellitus and conditions associated with diabetes mellitus.
Need to check novelty before this filing date? Find Prior Art